The intersection of sustainable development and pharmaceutical security is critical for effective obstetric and gynaecological care in Libya. Political instability and economic challenges have undermined medicine supply chains, directly impacting maternal and reproductive health outcomes. This policy analysis evaluates the coherence and effectiveness of Libyan national policies concerning pharmaceutical security within a sustainable development framework, from an obstetric and gynaecological perspective. It aims to identify key policy gaps and their implications for women's healthcare. A qualitative document analysis was conducted. This involved a systematic review of publicly available Libyan national policy documents, strategic health plans, and relevant international reports. The analysis employed a deductive framework aligned with sustainable development and health security principles. The analysis identified a significant disconnect between high-level sustainable development commitments and practical pharmaceutical procurement and distribution strategies for women's health. Policies were predominantly reactive, focusing on crisis management rather than resilient system-building. They lacked concrete provisions for securing essential medicines, such as oxytocin and magnesium sulphate, which are vital for preventing maternal mortality. Libyan policy frameworks have failed to integrate pharmaceutical security for obstetric and gynaecological care into a sustainable development agenda. This has rendered essential medicine supplies vulnerable to disruption, with detrimental consequences for women's health. Future policy must explicitly link pharmaceutical security to sustainable development targets. Recommendations include establishing a national essential medicines list for reproductive health, developing buffer stocks for critical obstetric drugs, and fostering regional manufacturing partnerships to reduce import dependency. Policy analysis, pharmaceutical security, sustainable development, maternal health, Libya, gynaecology, obstetrics This article provides a focused policy analysis linking sustainable development to pharmaceutical security within the specific context of Libyan women's healthcare, offering evidence for targeted health system strengthening.
Al-Tawil et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: